Aspirin and Reye Syndrome Risk in Children
Any dose of aspirin can potentially trigger Reye syndrome in children under 18 years old with acute viral illnesses, particularly influenza and varicella, and therefore aspirin should not be used in this population for fever or viral symptoms. 1, 2, 3
The Critical Issue: It's Not About the Dose
The evidence demonstrates that no dose of aspirin can be considered safe when a child has a viral infection 4. While research shows a dose-response relationship exists (with case-patients receiving median doses of 25.1 mg/kg average daily dose versus 14.5 mg/kg in controls), the excess risk was primarily associated with intermediate doses of 15-27 mg/kg per day rather than only high doses 5. This means even therapeutic, "low" doses carry risk during viral illness.
Clear Contraindications from Guidelines and FDA
The FDA drug label explicitly warns that children and teenagers recovering from chickenpox or flu-like symptoms should not use aspirin products 3. Multiple authoritative guidelines reinforce this:
- ACIP (Advisory Committee on Immunization Practices) recommends that aspirin or aspirin-containing products should not be administered to any person aged ≤18 years with suspected influenza 2
- The American Diabetes Association states aspirin therapy should not be recommended for patients under age 21 years because of increased Reye syndrome risk 6
- Children and adolescents aged 6 months to 18 years receiving long-term aspirin therapy are specifically identified as at risk for Reye syndrome after influenza virus infection 7, 8
The Exception: Medically Necessary Aspirin Use
For children who require chronic aspirin therapy for specific medical conditions (such as Kawasaki disease, stroke prevention, or juvenile arthritis), special precautions are mandatory 9:
- Annual influenza vaccination is reasonable to reduce Reye syndrome risk 9
- Varicella vaccination should be verified 9
- Aspirin should be withheld during suspected influenza or varicella infections 9
- Typical therapeutic doses used in these conditions range from 3-5 mg/kg per day, with no reports of Reye syndrome at these doses when viral infections are avoided 9
Clinical Characteristics of Reye Syndrome
Reye syndrome typically follows viral illness (particularly influenza B) with these features 1:
- Protracted vomiting and encephalopathy in afebrile patients 24-48 hours after viral symptoms
- Altered level of consciousness, lethargy, or extreme irritability
- Hepatic dysfunction with elevated transaminases (>3-fold increase in ALT/AST)
- Elevated ammonia levels
- Hepatomegaly in 50% of cases
- Mortality has decreased from 50% to less than 20% with earlier diagnosis, but remains at 31% in some series 1
The Dramatic Epidemiologic Evidence
The incidence of Reye syndrome declined dramatically following warnings about aspirin use in children 1, 10. This temporal relationship, combined with the dose-response data and biological plausibility (aspirin impairs mitochondrial enzyme function at therapeutic concentrations in susceptible individuals) 4, provides compelling evidence for causality despite the syndrome's rarity.
Common Pitfalls to Avoid
- Do not assume over-the-counter "children's aspirin" is safe during viral illness - any aspirin formulation carries risk 3
- Aspirin-containing combination products (like bismuth subsalicylate/Pepto-Bismol) must also be avoided 2
- For fever relief in children with viral illness, use acetaminophen or ibuprofen instead 2
- Children under 4 years should not receive over-the-counter cold medications without consulting a healthcare provider first 2